Targeting Bruton’s Tyrosine Kinase in CLL

by Inhye E. Ahn, Jennifer R. Brown
Published 2021-06-01

Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study

by Jennifer A. Woyach, Paul M. Barr, Thomas J. Kipps, Jacqueline C. Barrientos, Inhye E. Ahn, Paolo Ghia, Vincent Girardi, Emily Hsu, Mandy Jermain, Jan A. Burger
Published 2023-01-01

Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib

by Candida Vitale, Inhye E. Ahn, Mariela Sivina, Alessandra Ferrajoli, William G. Wierda, Zeev Estrov, Sergej N. Konoplev, Nitin Jain, Susan O’Brien, Mohammed Farooqui, Michael J. Keating, Adrian Wiestner, Jan A. Burger
Published 2016-06-01

Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma

by Reid W. Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Gabriela Spilberg, Matthew Robertson, Eleanor Taranto, Gulrayz Ahmed, Matthew Chase, Erin Jeter, Inhye E. Ahn, Jennifer R. Brown, Jennifer Crombie, Matthew S. Davids, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Gilles Salles, Andrew D. Zelenetz, Philippe Armand, Heiko Schöder, Heather Jacene
Published 2023-02-01